Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified April 2013 by Peking Union Medical College
Sponsor:
Information provided by (Responsible Party):
LI Taisheng, Peking Union Medical College
ClinicalTrials.gov Identifier:
NCT01844310
First received: August 25, 2012
Last updated: April 26, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)